Our team includes some of the world’s most respected oligonucleotide chemists, drug development experts, and dedicated patient advocates.
Paul Bolno, MD, MBA President and Chief Executive Officer
Chris Francis, PhD Senior Vice President, Corporate Development, Head of Emerging Areas
Daryn Lewis Senior Vice President, Head of Human Resources
Anne-Marie Li-Kwai-Cheung, MChem, MTOPRA, RAPS Chief Development Officer
Kyle Moran, CFA Chief Financial Officer
Linda Rockett, JD Senior Vice President, General Counsel
Sridhar Vaddeboina, PhD Senior Vice President, Chemistry, Manufacturing, and Controls
Chandra Vargeese, PhD Chief Technology Officer
Ginnie (Hsiu-Chiung) Yang, PhD Senior Vice President, Translational Medicine
Board of Directors
Christian Henry, MBA Chief Executive Officer, Pacific Biosciences
Paul Bolno, MD, MBA President and Chief Executive Officer, Wave Life Sciences
Mark H. N. Corrigan, MD Formerly Chief Executive Officer, Correvio Pharma Corp.
Peter Kolchinsky, PhD Founder and Managing Partner, RA Capital Management L.P.
Aik Na Tan Senior Vice President (Administration), Nanyang Technological University, Singapore
Adrian Rawcliffe Chief Executive Officer, Adaptimmune Therapeutics plc
Ken Takanashi, MBA, CPA Executive Vice President, Representative Director, Shin Nippon Biomedical Laboratories Ltd.
Gregory Verdine, PhD Erving Professor of Chemistry, Harvard University and Vice Chairman, FOG Pharmaceuticals
Heidi L. Wagner, JD Global Head of Government Affairs, ElevateBio, LLC